← FDA Drug Approvals (Drugs@FDA)

WIDAPLIK

NDA · New Drug Application · Sponsor: AZURITY · Approved 2025-06-05

Drug application

FDA Application #

NDA219423

Application type

New Drug Application

Brand name

WIDAPLIK

Generic name

TELMISARTAN, AMLODIPINE AND INDAPAMIDE

Active ingredients

AMLODIPINE BESYLATE; INDAPAMIDE; TELMISARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Azurity Pharmaceuticals, Inc.

First approval

2025-06-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown